Fetal Growth Retardation Clinical Trial
Official title:
Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
NCT number | NCT06039319 |
Other study ID # | 4967 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | November 1, 2022 |
Est. completion date | June 30, 2024 |
Objectives / Specific Aims - The purpose of this study is to investigate the acute effects of a single bout of moderate intensity maternal exercise on fetal well-being in a pregnancy affected by fetal growth restriction. Fetal well-being will be measured by biophysical profile (BPP), non-stress test (NST) and umbilical artery dopplers. - The hypothesis is that a single bout of maternal exercise will not significantly alter fetal well-being or fetal status.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Inclusion Criteria - FGR population - Age 18-45 - Intrauterine pregnancy with diagnosis of fetal growth restriction (FGR) as defined by total estimated fetal weight <10%ile for EGA or abdominal circumference <10%ile for EGA - Diagnosis of FGR at any point in gestation (preference given for inclusion of those diagnosed with FGR after 32w0d) - Gestational age between 28w0d and 36w6d at time of intervention (based on sure last menstrual period (LMP) confirmed by first or second trimester ultrasound or unsure LMP with first trimester ultrasound) - Compliant with standard prenatal care Inclusion Criteria - Average for gestational age (AGA) population - Age 18-45 - Intrauterine pregnancy with normal estimated fetal growth (EFW >10%ile and <90%ile) - Gestational age between 28w0d and 36w6d at time of intervention with accurate dating (based on sure LMP confirmed by ultrasound prior to 22 weeks or unsure LMP with first trimester ultrasound) - Compliant with standard prenatal care Exclusion Criteria: - Exclusion Criteria - FGR population - Known contraindication to completion of 30 minutes of moderate intensity exercise - Fetal umbilical artery with elevated S/D ratio or absent or reversed diastolic flow - BMI >40 - Severe maternal anemia (Hb less than 8.0) - Placenta previa - 2nd or 3rd trimester vaginal bleeding - Preterm premature rupture of membranes - Cervical insufficiency - Multi-fetal gestation - Oligohydramnios - Hypertensive disorder requiring antihypertensive medication - Blood pressure >140/90 on the day of the study visit prior to exercise - Tobacco use - Opioid agonist therapy - Known fetal chromosomal anomaly, structural anomaly or infection - Inability or unwillingness of subject to give informed consent - Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principle investigators Exclusion Criteria - AGA population - Known contraindication to completion of 30 minutes of moderate intensity exercise - BMI >40 - Severe maternal anemia (Hb less than 8.0) - Placenta previa - 2nd or 3rd trimester vaginal bleeding - Preterm premature rupture of membranes - Cervical insufficiency - Multi-fetal gestation - Oligohydramnios - Hypertensive disorder requiring antihypertensive medication - Blood pressure >140/90 on the day of the study visit prior to exercise - Tobacco use - Opioid agonist therapy - Known fetal chromosomal anomaly, structural anomaly or infection - Inability or unwillingness of subject to give informed consent - Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principle investigators |
Country | Name | City | State |
---|---|---|---|
United States | University of Tennessee Graduate School of Medicine | Knoxville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
University of Tennessee Graduate School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in umbilical artery dopplers systolic/diastolic ratio from pre to post exercise | Change in physiological assessment of umbilical artery dopplers systolic/diastolic ratio measured using ultrasound | Pre to immediately post acute exercise | |
Secondary | Change in uterine artery dopplers from pre to post exercise | Change in physiological assessment of uterine artery dopplers measured using ultrasound | Pre to immediately post acute exercise | |
Secondary | Change in fetal middle cerebral arterial (MCA) dopplers pulsatility index from pre to post exercise | Change in physiological assessment of fetal middle cerebral arterial (MCA) dopplers pulsatility index measured using ultrasound | Pre to immediately post acute exercise | |
Secondary | Biophysical Profile (BPP) pre exercise | Physiological assessment of Biophysical Profile (BPP) pre exercise using ultrasound, which assesses and scores fetal wellbeing in the following areas: body movement, muscle tone, breathing movements, and amniotic fluid volume. Each component of the biophysical profile receives a score of 0-2, with a total potential score ranging from 0-8. A score of 0 reflects fetal a fetal emergency and/or ominous fetal status and a score of 8 is regarded as "reassuring" which means normal. | Pre exercise (within 1 hour of the start of acute exercise bout) | |
Secondary | Time to complete Biophysical Profile (BPP) pre exercise | Time to complete physiological assessment of Biophysical Profile (BPP) pre exercise. | Pre exercise (within 1 hour of the start of acute exercise bout) | |
Secondary | Biophysical Profile (BPP) post exercise | Physiological assessment of Biophysical Profile (BPP) post exercise using ultrasound, which assesses and scores fetal wellbeing in the following areas: body movement, muscle tone, breathing movements, and amniotic fluid volume. Each component of the biophysical profile receives a score of 0-2, with a total potential score ranging from 0-8. A score of 0 reflects fetal a fetal emergency and/or ominous fetal status and a score of 8 is regarded as "reassuring" which means normal. | Immediately post acute exercise | |
Secondary | Time to complete Biophysical Profile (BPP) post exercise | Time to complete physiological assessment of Biophysical Profile (BPP). | Immediately post acute exercise | |
Secondary | Change in blood glucose from pre to immediately post acute exercise | Change in physiological assessment of capillary blood glucose measured using glucometer | Pre (within 1 hour of the start of acute exercise bout) to immediately post acute exercise | |
Secondary | Change in blood lactate from pre to immediately post acute exercise | Change in physiological assessment of capillary blood lactate using lactate analyzer | Pre (within 1 hour of the start of acute exercise bout) to immediately post acute exercise | |
Secondary | Change in maternal mood | Change in maternal mood using the Brunel Mood Scale Questionnaire. The Brunel Mood Scale is a 32-item questionnaire of current mood descriptors, assessed via 5-point Likert scale questions ("not at all" 0 to "extremely" 4). Mood descriptors are arranged into 8 different subscales (anger, confusion, depression, fatigue, tension, vigor, happiness, calmness), which have a scoring range from 0-16. Higher scores correspond to greater presence of the subscale. | Pre (within 1 hour of the start of acute exercise bout) to 20 minutes post exercise | |
Secondary | Change in maternal anxiety | Change in maternal anxiety using the State Trait Anxiety Inventory (STAI) forms Y1 (20 items) and Y2 (20 items) which assess state and trait anxiety. Each STAI item is given a weighted score of 1 to 4. Scores for both the state anxiety and trait anxiety scales can vary from a minimum of 20 to a maximum of 80, where a higher score reflects higher anxiety. | Pre (within 1 hour of the start of acute exercise bout) to 20 minutes post exercise |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT04502823 -
Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler
|
N/A | |
Not yet recruiting |
NCT03625518 -
Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes
|
Early Phase 1 | |
Completed |
NCT05176041 -
SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
|
||
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A | |
Completed |
NCT01695070 -
Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies
|
Phase 4 | |
Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
Completed |
NCT04289350 -
Day to Day Variation in Fetal Heart Rate Variability
|
||
Recruiting |
NCT03662178 -
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
|
||
Recruiting |
NCT05023161 -
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
|
||
Completed |
NCT02590536 -
A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction
|
Phase 3 | |
Not yet recruiting |
NCT05029778 -
Arginine + Citrulline as a Supplement for Weight Gain in Fetus With a Decrease in Their Growth Curve
|
Phase 4 | |
Recruiting |
NCT05576207 -
BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)
|
N/A | |
Active, not recruiting |
NCT05160649 -
Effect of Covid 19 Infection on Fetomaternal Outcome
|
||
Completed |
NCT02280031 -
Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.
|
Phase 2 | |
Recruiting |
NCT04389099 -
MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivo
|
||
Recruiting |
NCT05651347 -
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
|
Phase 3 | |
Recruiting |
NCT02336243 -
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
|
Phase 3 | |
Active, not recruiting |
NCT01594463 -
Routine Ultrasound Screening in the Third Trimester
|
N/A | |
Completed |
NCT00465634 -
Doppler and Biological Second Trimester Placental Insufficiency Screening
|
N/A |